We are live on
!
Find out more
PC
Pier Capital Portfolio holdings
AUM
$755M
1-Year Est. Return
94.38%
This Fund
S&P 500
This Quarter
Est. Return
-0.46%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$965M
AUM Growth
-$32.4M
(-3.2%)
Cap. Flow
-$6.96M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
14.62%
Holding
124
New
8
Increased
41
Reduced
62
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Latham Group
SWIM
|
+$11.3M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$8.77M |
| 3 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$8.26M |
| 4 |
Blend Labs
BLND
|
+$7.42M |
| 5 |
MaxCyte
MXCT
|
+$7.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TG Therapeutics
TGTX
|
+$10.9M |
| 2 |
RAVN
Raven Industries Inc
RAVN
|
+$10.6M |
| 3 |
FIVE9
FIVN
|
+$9.79M |
| 4 |
Sprout Social
SPT
|
+$7.13M |
| 5 |
Papa John's
PZZA
|
+$6.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.88% |
| 2 | Healthcare | 23.27% |
| 3 | Industrials | 16.26% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Financials | 7.76% |
Similar funds
HCM
FSCM
RMC
BEC
MWA
TPW
OM
MGM
Pier Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Pier Capital held 124 positions worth $965M, down 3.2% from $997M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pier Capital's Q3 2021 filing shows 8 new, 41 increased, 62 reduced and 5 closed positions. Its largest new stake was Latham Group: 485,886 shares worth $7.97M. The largest sale was TG Therapeutics, an estimated $10.9M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Pier Capital's largest Q3 2021 buy was Latham Group: 485,886 shares worth $7.97M.
- Pier Capital added most to Poshmark, Inc. Class A Common Stock in Q3 2021, an estimated $8.26M increase.
- Pier Capital's biggest Q3 2021 reduction was Sprout Social, cutting an estimated $7.13M.
- Pier Capital fully exited TG Therapeutics in Q3 2021, selling an estimated $10.9M.
- Pier Capital's ten largest holdings make up 15% of its $965M portfolio in Q3 2021.
- Pier Capital opened 8 new positions and closed 5 in Q3 2021.
- Pier Capital's portfolio value fell 3.2% quarter-over-quarter to $965M.
Based on Pier Capital's 13F filing for Q3 2021, filed 10 Nov 2021.